Controlled substances; Schedule I; psilocybin; revise a provision

Replaced the introductory committee explanation with a formal header identifying the bill as a committee substitute and listing the sponsors.

Adjusted page numbering and whitespace formatting throughout the document to standardize the layout.

Added a new title for the act, the 'Prescription Drug Security, Supervision, and Return Act,' indicating a broader legislative intent beyond just psilocybin.

Included a new provision revising the definition of lysergic acid diethylamide (LSD) to align with federal scheduling, expanding the bill's substance coverage.

Added a new section allowing pharmacy technicians to perform certain technical functions from a remote location, changing where these workers can operate.

Introduced new requirements for supervisory ratios between pharmacists and pharmacy technicians to ensure proper oversight.

Modified rules regarding wholesale drug distributors, removing the requirement that they must only accept returns of drugs with expiration dates less than one year from the manufacturing date.

Added specific duties for pharmacists to ensure no employee performs tasks requiring professional judgment and to supervise pharmacy technicians physically at all times in the licensed area.

Revised the definition and handling of psilocybin to specify that the exemption applies only to federally approved crystalline polymorph psilocybin, narrowing the scope of the exemption.

Updated the legal definition of a 'pharmacy technician' to explicitly include support persons providing nonjudgmental technical services under pharmacist supervision.

Added a clause stating that the new scheduling provisions do not abrogate or affect the Board of Pharmacy's emergency powers under other laws.

Changed the document title from 'House Bill 382' to 'H. B. 382 (SUB)' to indicate it is a committee substitute.